Skin Cancer

Skin cancer is the most common type of cancer in the U.S. It occurs in more than a million people each year, including many older people. There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. Of the three, melanoma is the most serious. Skin cancer occurs when abnormal cells form and multiply in an uncontrolled way in the epidermis, or abnormal cells from the epidermis invade the dermis of the skin. Basal cell carcinoma, squamous cell carcinoma, and melanoma are skin cancers that are named for the epidermal cells from which they develop.
What is Skin Cancer?

Skin cancer is the most common type of cancer among light skinned individuals. It is the commonest cancer in the United States and in Australia. Each year, about one million people are diagnosed with this cancer. In 85 percent of these cases, the skin damage leading to the cancer occurs before an individual is 18.

Read More

Overview

Feature Articles

Latest Skin Cancer News and Research

Researchers discover key protein interaction driving skin cancer growth

Researchers discover key protein interaction driving skin cancer growth

Study uncovers diversity of cancer-associated fibroblasts in skin cancer

Study uncovers diversity of cancer-associated fibroblasts in skin cancer

Teledermoscopy offers reliable skin cancer diagnosis

Teledermoscopy offers reliable skin cancer diagnosis

Study links tanning bed use to rising melanoma rates in New England

Study links tanning bed use to rising melanoma rates in New England

Tight petticoat waist cord linked to skin cancer

Tight petticoat waist cord linked to skin cancer

Researchers awarded Synergy Grant to target tumor vessels and boost immunotherapy

Researchers awarded Synergy Grant to target tumor vessels and boost immunotherapy

Study identifies six cancer susceptibility genes

Study identifies six cancer susceptibility genes

Genomic technology used to improve understanding of Marjolin's ulcer

Genomic technology used to improve understanding of Marjolin's ulcer

New insights into melanoma metastasis reveal potential drug target

New insights into melanoma metastasis reveal potential drug target

Breast cancer patients struggle with several unmet emotional and financial concerns

Breast cancer patients struggle with several unmet emotional and financial concerns

Bias awareness helps bridge the gap between human and AI healthcare

Bias awareness helps bridge the gap between human and AI healthcare

Distinct immune profiles linked to adverse reactions from immunotherapy

Distinct immune profiles linked to adverse reactions from immunotherapy

Breast cancer mortality plummets by 44%, but alarming racial gaps persist

Breast cancer mortality plummets by 44%, but alarming racial gaps persist

Hormone hepcidin identified as potential trigger for psoriasis

Hormone hepcidin identified as potential trigger for psoriasis

New biomarker profiling enhances early detection of melanoma

New biomarker profiling enhances early detection of melanoma

Expert survey unveils underestimated health impacts of weather and climate on mortality

Expert survey unveils underestimated health impacts of weather and climate on mortality

Sweden reports drop in skin cancer rates for under 50s

Sweden reports drop in skin cancer rates for under 50s

Age-related fibroblast changes in males drive aggressive melanoma

Age-related fibroblast changes in males drive aggressive melanoma

Study links monoclonal B-cell lymphocytosis to elevated melanoma risk

Study links monoclonal B-cell lymphocytosis to elevated melanoma risk

Lifestyle interventions in patients after colorectal cancer treatment

Lifestyle interventions in patients after colorectal cancer treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.